Brief: Xbrane Biopharma Q2 EBITDA SEK -54.7 Million

Xbrane Biopharma AB

28/08/2024 07:00

Aug 28 (Reuters) - Xbrane Biopharma Q2 net income SEK -70.5 million.
* Q2 EPS SEK -0.05
* Q2 revenue SEK 52 million